Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9078 |
High Similarity |
NPD249 |
Approved |
0.9078 |
High Similarity |
NPD250 |
Approved |
0.8951 |
High Similarity |
NPD195 |
Approved |
0.8951 |
High Similarity |
NPD186 |
Discovery |
0.8707 |
High Similarity |
NPD283 |
Approved |
0.8671 |
High Similarity |
NPD185 |
Approved |
0.8591 |
High Similarity |
NPD3107 |
Discontinued |
0.8591 |
High Similarity |
NPD1369 |
Phase 2 |
0.8591 |
High Similarity |
NPD242 |
Approved |
0.8591 |
High Similarity |
NPD338 |
Approved |
0.8591 |
High Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.8552 |
High Similarity |
NPD166 |
Approved |
0.8533 |
High Similarity |
NPD339 |
Approved |
0.8531 |
High Similarity |
NPD193 |
Suspended |
0.8477 |
Intermediate Similarity |
NPD169 |
Phase 2 |
0.8446 |
Intermediate Similarity |
NPD548 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD219 |
Phase 3 |
0.8421 |
Intermediate Similarity |
NPD1732 |
Phase 3 |
0.8421 |
Intermediate Similarity |
NPD2624 |
Phase 2 |
0.8421 |
Intermediate Similarity |
NPD216 |
Approved |
0.8421 |
Intermediate Similarity |
NPD217 |
Approved |
0.8421 |
Intermediate Similarity |
NPD2646 |
Discontinued |
0.8421 |
Intermediate Similarity |
NPD220 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD218 |
Approved |
0.8333 |
Intermediate Similarity |
NPD4716 |
Approved |
0.8282 |
Intermediate Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD516 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD213 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD214 |
Approved |
0.805 |
Intermediate Similarity |
NPD247 |
Clinical (unspecified phase) |
0.8028 |
Intermediate Similarity |
NPD248 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD2647 |
Phase 3 |
0.7902 |
Intermediate Similarity |
NPD9632 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD1692 |
Approved |
0.7826 |
Intermediate Similarity |
NPD1777 |
Approved |
0.7826 |
Intermediate Similarity |
NPD1776 |
Approved |
0.7758 |
Intermediate Similarity |
NPD5666 |
Phase 2 |
0.7755 |
Intermediate Similarity |
NPD252 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD546 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD7988 |
Suspended |
0.7711 |
Intermediate Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD1412 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD7138 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD536 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD3083 |
Approved |
0.7517 |
Intermediate Similarity |
NPD870 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD9633 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD582 |
Approved |
0.745 |
Intermediate Similarity |
NPD194 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD549 |
Approved |
0.7379 |
Intermediate Similarity |
NPD9408 |
Phase 3 |
0.7356 |
Intermediate Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD5682 |
Phase 3 |
0.7356 |
Intermediate Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD7158 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD2630 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2632 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2631 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD9607 |
Approved |
0.7189 |
Intermediate Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD2876 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD9606 |
Approved |
0.7074 |
Intermediate Similarity |
NPD2824 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD4054 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD4074 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD171 |
Discontinued |
0.7016 |
Intermediate Similarity |
NPD2902 |
Phase 2 |
0.7016 |
Intermediate Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD3086 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD9374 |
Approved |
0.6914 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD3085 |
Phase 1 |
0.6894 |
Remote Similarity |
NPD775 |
Approved |
0.6879 |
Remote Similarity |
NPD3695 |
Approved |
0.6879 |
Remote Similarity |
NPD3696 |
Approved |
0.6846 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.6829 |
Remote Similarity |
NPD231 |
Clinical (unspecified phase) |
0.6823 |
Remote Similarity |
NPD4495 |
Phase 1 |
0.6818 |
Remote Similarity |
NPD1046 |
Clinical (unspecified phase) |
0.6783 |
Remote Similarity |
NPD9373 |
Approved |
0.677 |
Remote Similarity |
NPD1730 |
Discontinued |
0.6755 |
Remote Similarity |
NPD515 |
Phase 1 |
0.6735 |
Remote Similarity |
NPD307 |
Approved |
0.6703 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.6627 |
Remote Similarity |
NPD9605 |
Phase 3 |
0.6623 |
Remote Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.6616 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.6603 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6603 |
Remote Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.6593 |
Remote Similarity |
NPD1063 |
Phase 2 |
0.6579 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.6579 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.657 |
Remote Similarity |
NPD527 |
Clinical (unspecified phase) |
0.6566 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.6543 |
Remote Similarity |
NPD4240 |
Approved |
0.6538 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.6522 |
Remote Similarity |
NPD1430 |
Approved |
0.6522 |
Remote Similarity |
NPD1431 |
Approved |
0.6522 |
Remote Similarity |
NPD207 |
Discontinued |
0.6474 |
Remote Similarity |
NPD282 |
Approved |
0.6467 |
Remote Similarity |
NPD353 |
Discontinued |
0.6433 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.637 |
Remote Similarity |
NPD9375 |
Discontinued |
0.6358 |
Remote Similarity |
NPD9409 |
Discontinued |
0.6335 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6322 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6303 |
Remote Similarity |
NPD6840 |
Approved |
0.6294 |
Remote Similarity |
NPD8836 |
Approved |
0.6289 |
Remote Similarity |
NPD5486 |
Discontinued |
0.6242 |
Remote Similarity |
NPD9584 |
Phase 2 |
0.6211 |
Remote Similarity |
NPD1120 |
Approved |
0.6211 |
Remote Similarity |
NPD1121 |
Approved |
0.6193 |
Remote Similarity |
NPD5458 |
Discontinued |
0.6188 |
Remote Similarity |
NPD1058 |
Discontinued |
0.6181 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.6178 |
Remote Similarity |
NPD1127 |
Approved |
0.6178 |
Remote Similarity |
NPD1128 |
Approved |
0.6173 |
Remote Similarity |
NPD6112 |
Approved |
0.6169 |
Remote Similarity |
NPD8830 |
Phase 3 |
0.6162 |
Remote Similarity |
NPD796 |
Phase 2 |
0.6154 |
Remote Similarity |
NPD281 |
Approved |
0.6149 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.6135 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6131 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.6076 |
Remote Similarity |
NPD1356 |
Approved |
0.6076 |
Remote Similarity |
NPD1354 |
Approved |
0.6076 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.6075 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.6068 |
Remote Similarity |
NPD534 |
Phase 2 |
0.6068 |
Remote Similarity |
NPD537 |
Phase 2 |
0.6026 |
Remote Similarity |
NPD798 |
Discontinued |
0.6024 |
Remote Similarity |
NPD2253 |
Discontinued |
0.6018 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.6012 |
Remote Similarity |
NPD535 |
Approved |
0.601 |
Remote Similarity |
NPD4713 |
Clinical (unspecified phase) |
0.601 |
Remote Similarity |
NPD4714 |
Approved |
0.601 |
Remote Similarity |
NPD34 |
Approved |
0.601 |
Remote Similarity |
NPD4715 |
Clinical (unspecified phase) |
0.5988 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.5986 |
Remote Similarity |
NPD1816 |
Clinical (unspecified phase) |
0.5951 |
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.5949 |
Remote Similarity |
NPD691 |
Discontinued |
0.592 |
Remote Similarity |
NPD2451 |
Phase 2 |
0.592 |
Remote Similarity |
NPD2450 |
Phase 2 |
0.592 |
Remote Similarity |
NPD2452 |
Phase 2 |
0.592 |
Remote Similarity |
NPD2453 |
Phase 2 |
0.5918 |
Remote Similarity |
NPD9291 |
Approved |
0.5913 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.5909 |
Remote Similarity |
NPD9360 |
Approved |
0.5895 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.5879 |
Remote Similarity |
NPD9582 |
Phase 3 |
0.5857 |
Remote Similarity |
NPD6381 |
Phase 2 |
0.5844 |
Remote Similarity |
NPD8831 |
Approved |
0.5844 |
Remote Similarity |
NPD8833 |
Approved |
0.5837 |
Remote Similarity |
NPD6023 |
Discontinued |
0.5833 |
Remote Similarity |
NPD5627 |
Approved |
0.5817 |
Remote Similarity |
NPD757 |
Phase 3 |
0.581 |
Remote Similarity |
NPD245 |
Suspended |
0.5808 |
Remote Similarity |
NPD5665 |
Clinical (unspecified phase) |
0.5792 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.5786 |
Remote Similarity |
NPD78 |
Approved |
0.5786 |
Remote Similarity |
NPD9544 |
Approved |
0.5784 |
Remote Similarity |
NPD4089 |
Clinical (unspecified phase) |
0.5783 |
Remote Similarity |
NPD9550 |
Approved |
0.5783 |
Remote Similarity |
NPD9551 |
Approved |
0.5782 |
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.5779 |
Remote Similarity |
NPD4599 |
Clinical (unspecified phase) |
0.5778 |
Remote Similarity |
NPD5768 |
Phase 2 |
0.5774 |
Remote Similarity |
NPD1118 |
Discontinued |
0.5773 |
Remote Similarity |
NPD3849 |
Clinical (unspecified phase) |
0.5743 |
Remote Similarity |
NPD1915 |
Phase 1 |
0.5742 |
Remote Similarity |
NPD1368 |
Approved |
0.5735 |
Remote Similarity |
NPD4612 |
Discontinued |
0.5733 |
Remote Similarity |
NPD9416 |
Phase 3 |
0.5733 |
Remote Similarity |
NPD9417 |
Phase 3 |
0.5729 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.5729 |
Remote Similarity |
NPD5757 |
Discontinued |
0.5714 |
Remote Similarity |
NPD9366 |
Approved |
0.5708 |
Remote Similarity |
NPD4187 |
Clinical (unspecified phase) |
0.5707 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.5707 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.5705 |
Remote Similarity |
NPD237 |
Clinical (unspecified phase) |
0.5701 |
Remote Similarity |
NPD5703 |
Discontinued |
0.5684 |
Remote Similarity |
NPD3593 |
Approved |
0.5683 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.5674 |
Remote Similarity |
NPD1273 |
Discontinued |
0.5674 |
Remote Similarity |
NPD1017 |
Clinical (unspecified phase) |
0.5673 |
Remote Similarity |
NPD9704 |
Approved |
0.5646 |
Remote Similarity |
NPD429 |
Approved |
0.5642 |
Remote Similarity |
NPD3697 |
Discontinued |
0.5614 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.5611 |
Remote Similarity |
NPD4654 |
Phase 1 |
0.5607
|
Remote Similarity |
NPD6036 |
Suspended |